• About Us
  • Terms and Conditions
  • Privacy Policy
Saturday, April 17, 2021
MemoryWell
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers
No Result
View All Result
MemoryWell
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers
MemoryWell
No Result
View All Result
Home My Alzheimer's Journey

My Alzheimer’s journey: Looking for a unicorn

Biogen's failed drug trial leaves Phil Gutis seeking more answers for Alzheimer's

Phil Gutis by Phil Gutis
August 23, 2019
in My Alzheimer's Journey
0
Phil Gutis gets a scan wearing his unicorn slippers.

Phil Gutis gets a scan wearing his unicorn slippers.

0
SHARES
Share on FacebookShare on Twitter

Last March, a much-anticipated drug trial for a possible Alzheimer’s treatment was cancelled after a “futility analysis” found that the “trials were unlikely to meet their primary endpoint upon completion.” In other words, Biogen, which created the drug, learned that its drug Aducanumab was unlikely to work.

I was one of the several thousand people who were part of that study.

In the months since then, I’ve written and talked extensively about Biogen and its failed trial. I’ve also schlepped down to the study site at the University of Pennsylvania via car service for two more safety visits: more blood work, more poking by a neurologist, more memory testing and additional MRIs.

My final visit occurred recently. It started as they all did when the car service pulled into our driveway. But unlike most of the trips to Penn, my husband Tim accompanied me that day; he was needed for the memory testing portion of the testing and otherwise spent a lot of time sitting around while I was shuttled from room to room.

By the end of the day, I was exhausted. I’d spent what felt like an extra-long time in the MRI tube and the memory/cognitive testing was extensive. At the same time, the emotional impact of the day was overwhelming.

I began my Alzheimer’s journey through the Biogen study. It was through the initial MRIs and a PET scan that I received my diagnosis of early-onset Alzheimer’s at age 54. And for nearly three years after, once a month, like the beat of a metronome, I was in a chair at the Penn Memory Center, attached to an IV drip bag as a low dose of Aducanumab dripped into my veins for about an hour. (In a letter after the trial’s failure, Biogen told participants if they had been receiving a low dose of Aducanumab, a high dose or a placebo.)

My participation in the trial became an important part of my identity, a way to make a difference in this surreal world of Alzheimer’s where not only is there no cure, there are not even real treatment options. And not much hope of an immediate treatment or cure.

Those monthly appointments stood out as my calendar cleared. I had stepped down as the director of a small not-for-profit near my house as even the pressure of that small job became too much. And then, after I qualified for Social Security disability, I officially retired at age 57.

As one social worker noted, this was clearly not the way I expected to spend my mid-50s. After decades spent in fairly high stress jobs as a senior communications officer for major not-for-profits, I was suddenly looking at a calendar with acres of empty space punctuated by twice daily reminders to take my medications.

Don’t get me wrong. It wasn’t that I crawled into bed after my diagnosis and pulled my blanket over my head. In fact, my first reaction to my diagnosis was to call the Alzheimer’s Association’s media department and start to explore ways that I could write about this disease.

Now an Alzheimer’s advocate

From that initial call, I became an Alzheimer’s advocate: I spent a year on a national early-stage advisory group for the association. I’ve told my story before dozens of conferences and to media interviewers. I’ve written for multiple publications. It’s been a pretty wild ride, but still nothing like my old jobs.

I’ve also tried to stay as optimistic about my future as possible. I urge folks to learn to “live” with Alzheimer’s … to experience as much as possible and make new memories even as the old ones fade away. (And, yes, those new memories also tend to disappear quickly but if you write about them and post photographs and share them with friends and family, you’ll always have someone and something to remind you. It’s far from the real things memory wise but it is better than nothing.)

Phil Gutis gets an infusion of a drug aimed at curbing the effects of his early onset Alzheimer’s.

Part of my determination to live with Alzheimer’s was the launch of a “campaign” that I called the silly shoe project. Inspired by Pam Montana, who served with me on the early-stage advisory council, I decided to wear a pair of silly shoes to each of my infusions, photograph myself and then post the image on social media. The goal was to encourage people to participate in clinical trials and my tag line became “have fun while doing good.”

Pam inspired the silly shoe challenge because she would always wear a different pair of Katy Perry shoes to her drug trial infusions. I couldn’t quite match her designer level so I came up with silly shoes: fish flip flops, hobbit feet slippers, elf shoes, glittering red stiletto boots.

Friends started to send me silly shoes — marijuana leaf flip flops from Bill Cluck, dachshund slippers from Emily Whitfield and a pair of unicorn slippers from Shin Inouye.

I hadn’t had a chance to wear the unicorn slippers before the cancellation of the trial, but I was able to use them on my last visit to the MRI as part of the Biogen study.

I thought my footwear choice was appropriate for that last visit of a failed drug trial that had launched with such optimism.

If unicorns were real, I explained to Tim, then just perhaps a treatment or cure for Alzheimer’s could be found before it was too late for me.

Tim teared up … we both know that unicorns are unfortunately not real and it is highly unlikely that a cure or treatment will be found in time for us.

But we push forward. I’m looking into new trials, launching new ideas — trying to convince people to pick up a piece of plastic everyday is my latest “brainstorm.” We got a new puppy, we’ve hired a designer to help us update our kitchen, we’re working with my nephew Ethan on our designer toy collection.

And I continue to tell my story through opportunities like this journal on MemoryWell and my frequent appearances on The Alzheimer’s Podcast hosted by my good friend Christy Turner (aka the Dementia Sherpa).

After all, unicorns are not real, a cure or treatment for Alzheimer’s is unlikely to come along soon enough to help me but I do firmly believe I can continue to do good and have some fun along the way.

Phil Gutis

Phil Gutis is a former New York Times reporter and civil liberties and environmental advocate who was diagnosed with early-onset Alzheimer’s in 2016.

Previous Post

My Alzheimer's journey: Should I have flossed more?

Next Post

My Alzheimer's journey: Falling into the memory holes

Related Posts

Phil Gutis gets an infusion as part of a drug trial that eventually failed.
My Alzheimer's Journey

My Alzheimer’s Journey: Failing again

Featured

My Alzheimer’s Journey: Dr. Oz reminds us to look for early signs of the disease

My Alzheimer's Journey

My Alzheimer’s journey: A train trip gone wrong

Phil Gutis had forgotten about seeing Randy Rainbow, but this photo brought back part of the memory.
My Alzheimer's Journey

My Alzheimer’s journey: Falling into the memory holes

Rep. Brian Fitzpatrick, second from right, honors Phil Gutis, third from right, and members of his rowing club.
My Alzheimer's Journey

My Alzheimer’s journey: Should I have flossed more?

Phil Gutis with Abe, who died earlier this year.
My Alzheimer's Journey

My Alzheimer’s journey: A new dog fills a hole in the soul

Next Post
Phil Gutis had forgotten about seeing Randy Rainbow, but this photo brought back part of the memory.

My Alzheimer's journey: Falling into the memory holes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest Posts

Resource List for Seniors

Award winner Rashi Ranjan of San Jose with her grandmother Pushpam Kusum

Young Authors Give Voice to Dementia

Award winner Rashi Ranjan of San Jose with her grandmother Pushpam Kusum

Student writers bring humanity to dementia through essays

Our Sponsors

Embracing Carers is an initiative led by EMD Serono, in collaboration with leading caregiver organizations around the world, to increase awareness and action about the often-overlooked needs of caregivers.

Our Members

Do YOU give a care? is an effort led by The SCAN Foundation to highlight the caregiving role that more than 10 million millennials are playing in their families.

Life Stories

  • Life Stories
Life Stories

Meet Roberta (Randy) Tidmore

by Madeleine Joung

Read more
No Result
View All Result
MemoryWell

© 2019 MemoryWell, LLC. All Rights Reserved.

  • About Us
  • Terms and Conditions
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers